Yanli Su

Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation

Yu-Wen Zhang, Yanli Su, Olga V. Volpert et al. · Proceedings of the National Academy of Sciences · 2003 · 342 citations · Full text

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Mark Merchant, Xiaolei Ma, Henry R. Maun et al. · Proceedings of the National Academy of Sciences · 2013 · 239 citations · Full text

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models

Brian Cao, Yanli Su, Marianne Oskarsson et al. · Proceedings of the National Academy of Sciences · 2001 · 214 citations · Full text

Antitumor Activity, Immunology, Growth Factor/scatter Factor +19

Proliferation and invasion: Plasticity in tumor cells

Chong Gao, Qian Xie, Yanli Su et al. · Proceedings of the National Academy of Sciences · 2005 · 172 citations · Full text

Biological Microenvironments, Pathology, Tumor Cells +16

Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations

Kyle Furge, Julie Koeman, Karl Dykema et al. · Proceedings of the National Academy of Sciences · 2007 · 135 citations · Full text

Genetics, Epigenetics, Tumor Biology +16